In cancer cells, ectopic expression of DiRas1 inhibits basal and RhoA-mediated NF-kB activity (Bergom et al., 2016) and provokes responses that can be attributed to reduced signaling by Ras and Rho family members [reviewed in Li et al. (2019)]. Here, DIRAS1 is linked to cancer.